| Name | Title | Contact Details |
|---|
US Post Acute Care is a Management Services Organization providing value-added service to clinical practice groups specializing in the care of patients in the post-acute setting. An organization with a national footprint, US Post Acute Care provides a full array of management services including billing, recruiting, training, compliance, analytics, and practice development. US Post Acute Care structures its services offering both to serve the needs as well as leverage the capabilities of its clinicians: the physicians and advanced practitioners dedicated to improving the quality of care for their patients. US Post Acute Care has designed and launched a proprietary clinical excellence program called SmartPAC™, a comprehensive clinical program for post-acute care designed to enable practitioners to improve patient outcomes with better quality care. Please
Integrated Healthcare Holdings, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Integrated Healthcare Holdings, Inc. is based in Santa Ana, CA. You can find more information on Integrated Healthcare Holdings, Inc. at www.ihhioc.com
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Cropper Medical is a Ashland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community Health Center Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Leandro, CA. To find more information about Community Health Center Network, please visit www.chcnetwork.org